TODAY is the first day of the 2024 Biotech Discovery Labs Program! We're looking forward to hearing what our participating Milwaukee Public Schools teachers think about the training this week. Learn more + watch the journey of this program from creation to implementation in the classroom! bit.ly/3WowIPd #scied #meded #genetherapy #biotech
American Society of Gene & Cell Therapy
Non-profit Organizations
Waukesha, WI 28,618 followers
ASGCT is the primary membership organization for professionals working in gene and cell therapy.
About us
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
- Website
-
http://www.asgct.org
External link for American Society of Gene & Cell Therapy
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Waukesha, WI
- Type
- Nonprofit
- Founded
- 1996
Locations
-
Primary
Get directions
20800 Swenson Dr.
Suite 300
Waukesha, WI 53186, US
Employees at American Society of Gene & Cell Therapy
-
Ravishankar Vadali
-
Serene Forte, PhD, MPH
Rare Diseases | Genetic Medicines | Medical Affairs | Strategy and Leadership | Business Development | Commercialization
-
Aravind Asokan
Professor, Duke University; Biotech Founder
-
Katharine (Katy) Spink
COO & Managing Partner at Dark Horse Consulting Inc.
Updates
-
Check out this interview with Dr. Adriana Bankston, our inaugural AAAS/ASGCT Congressional Policy Fellow! Dr. Bankston is a role model for many in the science policy + advocacy space and starts her fellowship this fall in Washington, D.C. #ASGCTadvocacy https://lnkd.in/gFbQJc4i
-
-
📣 📣 Attention #ASGCT members: We want to hear from you! Take our first-ever Member Census and get a $10 Amazon gift card! This member-only opportunity allows you to shape the future of ASGCT. Login to your member dashboard today to access the Census and share your thoughts with us: https://lnkd.in/e_Hdmr8R
-
American Society of Gene & Cell Therapy reposted this
In May, the American Society of Gene & Cell Therapy invited six individuals who earned certificates from Muhimbili University of Health and Allied sciences and ASGCT to attend the Annual Meeting, held in Baltimore. Dr. Magdalena Lyimo wrote about her experience at the Annual Meeting and her hopes to continue her involvement in gene therapy development in Tanzania. Read more about her experience here: https://lnkd.in/gjXfVMwH #GeneTherapy #SubSaharanAfrica
-
The abstract submission deadline has been extended by ONE WEEK for Advancing Gene + Cell Therapies for Cancer! Submit your cancer-related #research by 🚨JULY 19🚨 for the opportunity to present alongside CGT and cancer experts in #Philadelphia, Oct. 16-17. Learn more here: https://bit.ly/3W4jozm #cancerresearch #cellandgenetherapy #CGT #submitresearch #callforabstracts
-
-
CGT news from the University Hospital Erlangen in Erlangen, Germany. “Simply the fact that we have administered CAR-T cells for an autoimmune disease is something special, since it was previously only authorized for certain advanced types of cancer,” explains Tobias Krickau, Uresa’s pediatric rheumatologist at the Department of Pediatrics and Adolescent Medicine (director Prof. Dr. Joachim Wölfle) at Universitätsklinikum Erlangen. “We initiated the CAR-T cell therapy for Uresa as part of an extended access program for severely ill patients in accordance with the German Medicinal Products Act and the Ordinance on Medicinal Products for Compassionate Use as something known as an individual treatment attempt.” Read more about this case: links to the study in The Lancet and the article in comments below.
Breakthrough in Cell Therapy: Lupus Patient’s Amazing Recovery 👇 In June 2023, 15-year-old Uresa A. received CAR-T cell therapy at Universitätsklinikum Erlangen to treat her aggressive systemic lupus erythematosus (SLE), making her the first child to undergo this treatment for an autoimmune disease. 👉 One year later, Uresa feels as good as before her diagnosis, with only minor colds. The therapy, typically used for certain cancers, had never been tried in children with autoimmune diseases. Kudos to both Ethan Brookes and Jason C. Foster for making me aware of this news. Fantastic milestone 👏 𝐈𝐬 𝐭𝐡𝐢𝐬 𝐚 𝐬𝐢𝐠𝐧 𝐭𝐡𝐚𝐭 𝐚𝐮𝐭𝐨𝐢𝐦𝐦𝐮𝐧𝐢𝐭𝐲 𝐢𝐬 𝐛𝐞𝐜𝐨𝐦𝐢𝐧𝐠 𝐚 𝐯𝐚𝐥𝐢𝐝𝐚𝐭𝐞𝐝 𝐩𝐢𝐯𝐨𝐭 𝐟𝐨𝐫 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲? #celltherapy #immunology #biotech #CGTweekly
-
-
Join ASGCT and the Muscular Dystrophy Association in Chicago (or virtually) Nov. 19-20, 2024. Have #musculardystrophy research to share? Less than one month to submit! Submit your abstract by August 9 at 11:59 p.m. ET for the opportunity to present your research in Chicago! https://lnkd.in/gv-C-n3a #cellandgenetherapy #CGT #ASGCT
Join American Society of Gene & Cell Therapy and the Muscular Dystrophy Association in Chicago November 19-20, 2024, for an unparalleled opportunity to explore the latest advancements in research on #GeneticTherapies for #MuscularDystrophy. This inaugural meeting will bring together leading researchers and clinicians from the #neuromuscular disease community to discuss cutting-edge genetic therapies and technologies. Have research to share? Submit your muscular dystrophy related abstracts through August 9 at 11:59 p.m. ET for the opportunity to present your research in-person in Chicago. Register or learn more here: https://lnkd.in/efS_XEW9 #ScientificResearch #ClinicalResearch #Research
-
-
Join ASGCT + #MolecularTherapy for a conversation between Drs. Paloma Giangrande + Marcin Kortylewski! They discuss an #MTNA article by Dr. Kortylewski and colleagues,"Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3." Listen here and let us know what you think. https://lnkd.in/gyFpYyHG
-
-
💡 Attention #CGT professionals! Are you attending the 2024 Policy Summit on September 23-24 in Washington, DC (or virtually)? Share your participation with colleagues! Here's how you can spread the word: Use our official hashtag: #ASGCTAdvocacy Tag the American Society of Gene and Cell Therapy in your post Share what you're most looking forward to at The Policy Summit! Need more ideas? Check out our comprehensive social media kit at asgct.org/policysummit for post templates, shareable graphics, and key talking points. #cellandgenetherapy #genetherapy #celltherapy #paymentpolicy
-
-
📢 ONE MORE WEEK to submit your abstracts for our Advancing Gene + Cell Therapies for Cancer Conference (#ASGCTAdvancing24)! Send us your research through Friday, July 12, for the opportunity to present it in Philadelphia! https://lnkd.in/g2JHc4rg Remember: Associate ASGCT members who are first and presenting accepted authors will receive discounted registration! #cancer #CGT #genetherapy #celltherapy
-